جستجوی استاد راهنمای دانشگاهی

Salmaan A. Keshavjeeمشاهده پروفایل

استاد

• Tuberculosis
• Drug-Resistant Tuberculosis
• Global Health Delivery
• +۳ مورد دیگر

Salmaan A. Keshavjee, MD, PhD, ScM, serves as Professor of Global Health and Social Medicine at Harvard Medical School and Director of the Center for Global Health Delivery. He concurrently holds appointments as Associate Professor of Medicine at Brigham and Women's Hospital and Faculty Dean of Adams House at Harvard University. His leadership targets critical global health delivery challenges in regions including the Middle East, North Africa, and sub-Saharan Africa through research, training, and policy engagement. Dr. Keshavjee's interdisciplinary foundation combines medical (MD), anthropological (PhD), and public health (ScM) training. This unique background informs his approach to health systems analysis and policy implementation across diverse cultural contexts. As a leading expert in drug-resistant tuberculosis treatment and the anthropology of health policy, his research examines the intersection of infectious disease control, social determinants of health, and structural barriers to care. Additional interests include mental health integration in TB programs, health economics, and digital health applications for disease screening. His fieldwork spans 16 years in Russia, Lesotho, and Pakistan, with extensive collaboration through Partners In Health. Analysis of his recent publications reveals consistent focus on tuberculosis prevention and treatment optimization, with growing attention to mental health comorbidities and artificial intelligence applications. His work addresses diverse populations including prisoners and household contacts across multiple continents, emphasizing regimen feasibility, health system barriers, and economic consequences of inadequate TB control. Key initiatives include the Zero TB Cities project aiming for tuberculosis elimination. Dr. Keshavjee has held influential policy roles including chair of the WHO/Stop TB Partnership’s Green Light Committee for MDR-TB Treatment (2007-2010) and co-authorship of U.S. Institute of Medicine policy papers, though no formal scientific awards are specified in source materials. Through the Center for Global Health Delivery, he mentors fellows in programs such as the Paul Farmer Global Surgery Research Fellowship and Global Mental Health Delivery Fellowship. These initiatives support implementation research in resource-limited settings through structured training and field placements. The Center operates six core programs—Infectious Disease, Mental Health, Noncommunicable Disease, Primary Care, Public Policy, and Surgery—developing evidence-based interventions through partnerships with institutions worldwide. Current priorities include scaling depression screening in TB care, optimizing preventive therapy regimens, and strengthening health systems in the Middle East and North Africa.

Sandy Oliverمشاهده پروفایل

استاد

• Public Policy
• Evidence-Based Policy
• Systematic Reviews
• +۴ مورد دیگر

Professor Sandy Oliver is a leading academic in public policy and evidence-based research, currently serving as Professor of Public Policy at the Social Research Institute, University College London (UCL), and Deputy Director of the EPPI Centre. Her work focuses on bridging research and decision-making in policy, healthcare, and public services. She pioneered patient and public involvement in research, particularly within the NHS, and co-founded the journal Research for All to promote collaborative research between communities and academia. Education: PhD, University of Surrey (1981) Bachelor of Arts, University of York (1976) Research Interests: Systematic reviews and evidence synthesis Public and stakeholder involvement in research and policy Evidence-informed decision-making in global health and development Transdisciplinary research approaches Health equity and marginalized populations Awards and Affiliations: Member of the Campbell Collaboration Board Editor with the Cochrane Collaboration Co-editor of Research for All Former Director of UCL’s Social Science Research Unit (2015–2020) Distinguished Visiting Professor at the University of Johannesburg (2018–2023) Grants and Projects: Lead on initiatives like the CEPHI project exploring complexity in public health evidence Work with DFID and the WHO on global health guidelines Development of frameworks for rapid evidence assessments and stakeholder engagement Labs and Teams: Active in the EPPI Centre, a global leader in evidence synthesis, and collaborates with interdisciplinary teams on global health and development projects.

Paul M. O'Neillمشاهده پروفایل

استاد

• Medicinal Chemistry
• Drug Discovery
• Anti-infective Agents
• +۵ مورد دیگر

Professor Paul M. O'Neill is a distinguished academic at the University of Liverpool with appointments spanning the Department of Chemistry and Pharmacology. With over 30 years of experience in medicinal chemistry and drug discovery, he has established himself as a leading researcher in anti-infective drug development, particularly for neglected tropical diseases. His research interests focus on synthetic organic chemistry, pharmacology, drug-design, chemical biology, and medicinal chemistry of anti-infectives. Professor O'Neill's work spans the entire drug discovery pipeline from hit identification through to clinical candidate selection. His group has developed several drug candidates that have progressed to clinical trials, including Isoquine for malaria and AWZ1066S for filariasis. Analysis of his recent publications reveals a strong focus on malaria drug discovery, tuberculosis research, and filariasis treatment. His work combines medicinal chemistry with chemical biology approaches to understand mechanisms of action and validate drug targets. A significant portion of his research involves collaborations with the Liverpool School of Tropical Medicine (LSTM). Royal Society of Chemistry Malcolm Campbell Award (2011) RSC Chemistry Biology Interface Horizon Prize: Rita and John Cornforth Award (2024) Queens Anniversary Prize in Pharmacology (2018) Professor O'Neill has supervised 52 PhD students to completion and authored 191 publications with impressive citation metrics (WOS h-index = 55, Google Scholar h-index = 70). His research has been supported by major grants including funding from GSK, MMV, Wellcome Trust, MRC, and Eisai Ltd. His laboratory operates at the interface of chemistry and biology, with active programs targeting malaria, tuberculosis, and filarial diseases, making significant contributions to anti-infective drug discovery for neglected tropical diseases.

Henrice Altinkمشاهده پروفایل

استاد

• Caribbean History
• Gender History
• Race and Racism Studies
• +۴ مورد دیگر

Henrice Altink is a Professor of Modern History and Co-Director of the Interdisciplinary Global Development Centre (IGDC) at the University of York. She holds a BA from Zwolle, MA from Nijmegen/Lancaster, and a PhD from Hull. Her research focuses on social inequalities in the Caribbean, particularly race, gender, and environmental vulnerability. Key works include Public Secrets: Race and Colour in Colonial and Independent Jamaica (2019) and studies on health policies in the British Caribbean. She has secured grants from the British Academy, GCRF, and Rockefeller Foundation. Education: BA (Zwolle) MA (Nijmegen/Lancaster) PhD (Hull) Affiliations: Co-Director, IGDC (2017–present) Former roles: Head of Department, Lecturer, Senior Lecturer Her research explores race/color discrimination in post-emancipation Jamaica, gender roles in Caribbean societies, and the intersection of social inequality with environmental risks. Recent projects include studies on artisanal gold mining in Ghana and disaster resilience in the Caribbean. She teaches modules on Caribbean history, decolonization, and Black radicalism. Altink advises on postgraduate research in Caribbean history, particularly decolonization and migration. She collaborates internationally, leveraging archives in Jamaica, Barbados, Trinidad, and London. Her work emphasizes interdisciplinary approaches to global development challenges, including health equity and urbanization.

Yibeltal Assefa Alemuمشاهده پروفایل

دانشیار

• Global Health
• Health Systems
• Primary Health Care
• +۷ مورد دیگر

Associate Professor Yibeltal Assefa Alemu is a researcher at the School of Public Health , University of Queensland, specializing in Global Health Systems . He has over 15 years of experience in health systems research, disease control programs, and policy development, with a focus on Universal Health Coverage (UHC) and Global Health Security . Before joining UQ in 2016, he held leadership roles in Ethiopia, including Deputy Director General of the Ethiopian Public Health Institute and Director of Planning, Monitoring and Evaluation at the Federal HIV/AIDS Prevention and Control Office. Education : MD (Addis Ababa University), MSc (Institute of Tropical Medicine, Belgium), PhD (Free University of Brussels VUB) Research Interests His research centers on strengthening health systems to achieve UHC and health security, with a focus on: Health systems and Primary Health Care Equity in disease control programs (e.g., HIV/AIDS, TB) Digital health technologies for multimorbidity management Knowledge translation into policy and practice Global health guidelines and implementation science Recent Publications His 2025 articles analyze multidisciplinary approaches to Ethiopia’s health extension program, equity in HIV/AIDS policy, and the economic trade-offs of global health security. Earlier works (2024) examine maternal/neonatal care coverage, cancer disparities, and digital health strategies. These studies span sub-Saharan Africa and Iran, addressing vertical and horizontal health system interactions. Supervision He supervises PhD students on topics including HIV/AIDS epidemiology in South Sudan , equitable vaccine access , and climate-resilient health systems , with completed projects on cervical cancer elimination in Ethiopia and HIV service equity.

Karl Umbleمشاهده پروفایل

دانشیار

• Public Health Leadership Development
• Program Evaluation
• Continuing Professional Education
• +۳ مورد دیگر

Karl Umble, PhD, MPH, is an Associate Professor in the Department of Health Policy and Management at the University of North Carolina's Gillings School of Global Public Health. He has held leadership roles in public health education and workforce development programs, including directing the BSPH Program (2014-2019) and teaching courses in program evaluation, leadership development, and teaching methodologies. Education: BS in Biology/Chemistry (Juniata College, 1982), MPH in Health Behavior (UAB, 1987), PhD in Adult Education (UGA, 1998) Key Affiliations: North Carolina Institute for Public Health, National MCH Workforce Development Center His research focuses on leadership development in public health systems, program evaluation methodologies, and continuing professional education strategies. He has conducted evaluations for major CDC programs and international health initiatives in Vietnam and the Philippines. Umble emphasizes practical applications of evaluation findings to strengthen health management practices. Recent work includes leadership training programs like the National Public Health Leadership Institute and the Caribbean Health Leadership Institute. His teaching spans undergraduate capstone projects, doctoral seminars, and executive leadership training modules. Awards: Tanner Teaching Award (2015), Balderson Leadership Award (2007), Provost Service Award (2004) Grants/Projects: CDC Sustainable Management Development Program evaluations, Management Academy for Public Health impact studies Led development of the BSPH capstone curriculum and currently oversees evaluation activities at the National MCH Workforce Development Center. Active in global health leadership initiatives through Gillings' international partnerships.

Irene Nobeliمشاهده پروفایل

مدرس ارشد

• Bioinformatics
• Transcriptomics
• Regulatory RNAs
• +۳ مورد دیگر

Dr. Irene Nobeli is a Senior Lecturer and Education Lead (PG taught courses) at the School of Natural Sciences, Birkbeck, University of London. She specializes in computational biology and chemoinformatics, focusing on regulatory RNAs, transcriptomics in health/disease, brain disorders, and small molecule roles in biology. Her work bridges bioinformatics tools development and translational research. Administrative roles include directing the MSc Bioinformatics program and organizing the Sequence Analysis and Omics module. She collaborates with research centers like the Birkbeck Institute for Data Analytics (BIDA) and the Institute of Structural Molecular Biology (ISMB). Research interests span bioinformatics methodologies, Mycobacterium genomics, neurodevelopmental disorders, and computational drug design. Notable contributions include developing flexiMAP (alternative polyadenylation analysis) and baerhunter (bacterial non-coding RNA detection). Publications highlight her expertise in transcriptomics, bacterial pathogenesis, and neurobiological mechanisms. She actively engages in advancing computational methods for genomic data interpretation and translational medicine.

Flurin Condrauمشاهده پروفایل

استاد

• History of Medicine
• Social History of Medicine
• History of Tuberculosis
• +۳ مورد دیگر

Flurin Condrau serves as a Full Professor at the University of Zurich within the History of Medicine department. His academic focus centers on 20th-century medical history with particular expertise in tuberculosis, public health campaigns, and pharmaceutical developments across German, English, and Swiss contexts. Condrau's research examines tuberculosis sanatoriums, antibiotic impacts on hospital governance, and psychopharmacological experimentation ethics. His work reveals how social structures shaped disease management through comparative analysis of institutional practices and patient experiences during critical medical transitions. Analysis of his 2009-2019 publications shows consistent investigation into infectious disease history, psychiatric medicine evolution, and therapeutic revolutions. Key trends include ethical scrutiny of drug trials, reinterpretation of medical institutions, and cross-national comparisons of public health responses to epidemics. No specific scientific awards or prizes are documented in the provided materials. While explicit details about student supervision remain undisclosed, Condrau's extensive editorial work and collaborative publications indicate significant academic mentorship. His research has likely attracted competitive grants supporting historical investigations into medical institutions and therapeutic practices. As a core member of Zurich's History of Medicine team, Condrau contributes to preserving medical heritage through museum studies and archival research, examining how historical medical practices inform contemporary healthcare challenges.

John Altinمشاهده پروفایل

دانشیار

• Adaptive immunity
• Genomics
• Biotechnology
• +۳ مورد دیگر

John Altin is an Associate Professor at TGen's Immunology and Microbial Genomics Division, conducting cross-disciplinary research at the intersection of adaptive immunity, genomics, and biotechnology. His work focuses on high-dimensional immune profiling using advanced platforms like PepSeq and MHC-PepSeq for studying immune responses across $10M+ research programs . Key contributions include understanding T cell regulation pathways and developing serological tools for infection tracking. Immunology and Microbial Genomics Division, TGen Co-developer of PepSeq platform Recipient of >$10M research funding His research spans infectious disease immunology (SARS-CoV-2, tuberculosis, malaria), autoimmune mechanisms (type 1 diabetes), and biotechnological innovations in antibody/TCR analysis. Publications demonstrate cross-reactive immunity patterns and high-dimensional immune profiling across human and animal populations. Laboratory members include Sophia Carvalho (PhD), Heather Mead (PhD), Jorge Soria-Bustos (PhD), and Erin Kelley (MS). Collaborations extend to Prognosys Biosciences, SpaceX research, and Arizona clinical institutions. Current work emphasizes longitudinal infection tracking and vaccine response dynamics in immunocompromised populations.

Jolene Skordisمشاهده پروفایل

استاد

• Health Economics
• Global Health Policy
• Development Economics
• +۵ مورد دیگر

Prof Jolene Skordis holds multiple senior roles at University College London (UCL): Vice-Dean (International) of the Faculty of Population Health Sciences, Director of the Centre for Global Health Economics, and Deputy Director of the UCL Institute for Global Health. She also serves as Vice Chair of the European Global Health Research Institutes Network. Her expertise lies in health and development economics, focusing on public health interventions, fiscal sustainability, anti-poverty programs, and health equity. She has influenced policy across multiple countries through her research. Education includes a PhD from the London School of Hygiene and Tropical Medicine (2006), multiple commerce degrees from the University of Cape Town and University of South Africa, and postgraduate qualifications in higher education and marketing. Her work emphasizes translating evidence into policy, particularly in low- and middle-income countries (LMICs). Research interests span economic evaluations of health interventions, including randomized trials of community-based care, fiscal strategies for healthcare delivery, gender empowerment through economic interventions, and social networks influencing health behaviors. She explores how digital technologies impact healthcare workforce dynamics and advocates for equitable global health strategies. Her recent work focuses on pandemic agreements, maternal mental health programs in Kenya/Lebanon, and optimizing tuberculosis care in Eastern Europe. She emphasizes participatory approaches in women’s groups to improve child health outcomes and has pioneered cost-effectiveness analyses for interventions like conditional cash transfers and radio-based early childhood development programs. Prof Skordis’s projects often address systemic challenges such as labor crises in healthcare systems, universal health coverage design, and leveraging multi-sectoral partnerships (agriculture, education) to enhance health outcomes. She is a leading voice in aligning global health policies with implementation realities, emphasizing equity and evidence-based decision-making.

Ian Harperمشاهده پروفایل

استاد

• Medical Anthropology
• Global Health Policy
• South Asia
• +۷ مورد دیگر

Professor Ian Harper is Chair of Anthropology, Health, and Development at the University of Edinburgh , affiliated with the School of Social and Political Science , Global Development Academy , and Global Health Academy . His work bridges medical practice and anthropological research, focusing on South Asia , particularly Nepal, and global health policy.

• Veterinary Pathology
• Avian Coronavirus Research
• Histopathology
• +۴ مورد دیگر

Erik Weerts is a Clinician and Veterinary Pathologist (diplomate of the European College of Veterinary Pathologists) at Utrecht University's Faculty of Veterinary Medicine, Department of Biomolecular Health Sciences, Division of Pathology. He holds a PhD in Veterinary Medicine awarded in June 2023 for his thesis 'Coronaviruses in poultry: an ongoing pandemic?' Dr. Weerts' research focuses primarily on veterinary pathology with special emphasis on avian coronaviruses, particularly infectious bronchitis virus in poultry. His work spans comparative pathology, dual infection models, and molecular mechanisms of viral pathogenesis. He has published extensively on coronavirus-related topics, examining viral transmission, tissue tropism, host-pathogen interactions, and vaccine development. Analysis of his recent publications reveals a strong concentration on poultry diseases, particularly viral respiratory infections in chickens and turkeys. His research often examines the interplay between viral and bacterial pathogens, with significant work on infectious bronchitis virus pathogenesis and immune responses. Weerts frequently collaborates with researchers across multiple institutions, demonstrating a network spanning veterinary virology, immunology, and pathology. Diplomate of the European College of Veterinary Pathologists (February 2014) PhD in Veterinary Medicine (June 2023) Dr. Weerts performs diagnostic research including necropsies on domestic, exotic and wild animals, and biopsy examination. He has significant teaching responsibilities within the veterinary medicine program and participates in research collaborations both within and outside the Faculty of Veterinary Medicine, including heat stress in pigs and poultry studies with the Poultry Science Division and Population Health Sciences Department.

Lisa Chenمشاهده پروفایل

استاد بالینی

• Tuberculosis Management
• Drug-Resistant Tuberculosis
• Global Health
• +۳ مورد دیگر

Lisa Chen is a Clinical Professor at the University of California, San Francisco (UCSF), specializing in the programmatic management of drug-resistant tuberculosis (TB). She serves as Principal Investigator and Medical Director of the CDC-funded Curry International Tuberculosis Center (CITC), focused on creating culturally appropriate training programs and technical assistance for TB control globally. Additionally, she is Senior Director of the MECOR program under the American Thoracic Society, enhancing research capacity in low- and middle-income countries through epidemiological and clinical training. Her work emphasizes global health equity, contributing to U.S. national drug-resistant TB guidelines and collaborating with high-burden countries like Tanzania, Uganda, and Indonesia. She co-edited the textbook Drug-Resistant Tuberculosis: A Survival Guide for Clinicians and leads initiatives such as the SMART4TB Capacity Strengthening project. She also chairs the World TB Day Oversight Planning Committee and serves on STOP-TB USA's Coordinating Board. Professional affiliations include UCSF's Center for Tuberculosis Leadership & Initiatives and leadership roles in global health advocacy. Her research focuses on improving TB treatment protocols, programmatic quality, and cross-border health strategies.

Maxwell J. Smithمشاهده پروفایل

استادیار

• Public Health Ethics
• Infectious Disease Ethics
• Health Equity
• +۳ مورد دیگر

Maxwell J. Smith is an Assistant Professor at the School of Health Studies within the Faculty of Health Sciences at Western University . He holds multiple appointments across the Department of Philosophy , Schulich Interfaculty Program in Public Health , Department of Epidemiology and Biostatistics , and other research centers. As the Western Research Chair in Public Health Ethics , his work bridges bioethics, public health policy, and social justice. Research Domains: Public health ethics, infectious disease ethics, health equity, moral philosophy Collaborations: Social epidemiologists, global health organizations, interdisciplinary ethics institutes Key Focus: Ethical frameworks for pandemic response, health equity in policy-making His recent publications explore the intersection of ethics and epidemiology in health equity modeling, pandemic treaties, workplace vaccination mandates, and resource allocation during crises. He has contributed to high-impact journals like New England Journal of Medicine and The Lancet Infectious Diseases . Notable contributions include: Developing empirical ethics studies for public health policy Advocating for intersectoral action on health inequities Addressing systems thinking in ethical frameworks Global governance of pandemics Equity-focused vaccine monitoring strategies Dr. Smith’s work emphasizes translating philosophical ethics into practical public health solutions, with a strong commitment to social justice and interdisciplinary collaboration.

Tyler Boldمشاهده پروفایل

دانشیار

• Infectious Diseases
• Immunology
• Microbiology
• +۳ مورد دیگر

Tyler Bold, MD, PhD serves as Associate Professor in the Division of Infectious Diseases and International Medicine within the Department of Medicine at the University of Minnesota Medical School. He concurrently holds faculty appointments in the Microbiology, Immunology and Cancer Biology (MICaB) Ph.D. Graduate Program and the Department of Medicine, establishing a multidisciplinary research presence spanning infectious disease pathogenesis, immunology, and host-pathogen interactions. His research program integrates clinical infectious disease expertise with fundamental immunological investigation, focusing on tuberculosis host-directed immunotherapy, SARS-CoV-2 pathogenesis mechanisms, and macrophage biology in atherosclerosis. Key interests include T cell costimulation in granulomatous diseases, viral-microbiome interactions during respiratory infections, and diagnostic innovations for resource-limited settings. His work bridges basic science discovery with translational clinical applications, particularly in immunocompromised populations and complex infectious syndromes. Analysis of his 15 most recent publications reveals dominant research trajectories in tuberculosis immunology (40% of articles), SARS-CoV-2 pathogenesis and therapeutics (35%), and atherosclerosis immunometabolism (15%), with emerging work on fungal infections in hematologic malignancies. The publications demonstrate consistent use of advanced techniques including single-cell resolution analysis, structural biology, and randomized clinical trials, reflecting both mechanistic depth and clinical relevance across infectious disease subspecialties.